SC
BIIB icon

Sierra Capital’s Biogen BIIB Stock Holding History

Sierra Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-151
Closed -$31K – 676
2022
Q2 		$31K Sell
151
-6
-4% -$1.23K 0.01% 369
2022
Q1 		$33K Sell
157
-8
-5% -$1.74K 0.01% 378
2021
Q4 		$40K Buy
165
+14
+9% +$3.6K 0.01% 358
2021
Q3 		$43K Hold
151
– – 0.01% 314
2021
Q2 		$52K Hold
151
– – 0.01% 285
2021
Q1 		$42K Buy
+151
New +$40.7K 0.01% 284

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sierra Capital's BIIB Position: Q3 2022 in Review

Sierra Capital sold out of Biogen (BIIB) in Q3 2022, closing a stake of 151 shares — an estimated $31K sold.

Sierra Capital first reported a position in BIIB in Q1 2021 and held it in 6 quarters. The position peaked at $52K in Q2 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Sierra Capital reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Sierra Capital sold 151 Biogen shares in Q3 2022, an estimated $31K.
  • Sierra Capital first reported a position in Biogen in Q1 2021 and held it in 6 quarters.
  • Sierra Capital's Biogen position peaked at $52K in Q2 2021.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Sierra Capital's 13F filing for Q3 2022, filed 4 Nov 2022.